Adonis

Adonis is an investigational topical patch developed by the Shandong Institute of Biological Medicine for the treatment of recurrent aphthous ulcers (RAU), commonly known as canker sores. The product is designed for application to the oral mucosa, where it functions as a protective barrier to shield the ulcerated area from mechanical irritation and potentially delivers active pharmaceutical ingredients to promote wound healing and provide symptomatic relief. In 2015, Adonis entered a Phase 1 clinical trial in China (CTR20150602) to evaluate its safety and tolerance in human subjects. While the specific active chemical or biological components of the formulation are not widely disclosed in public clinical registries, the drug is categorized as a pharmaceutical product intended to address the localized inflammation and pain associated with recurrent oral lesions.

Brand names

Adonis

Other names

阿多尼斯口腔溃疡贴片